title: Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.
authors: L
authors: L
authors: Delhaes
authors: J-C
authors: JC
authors: Mraz
authors: E
authors: E
authors: Fréalle
authors: I
authors: I
authors: Durand-Joly
authors: L
authors: L
authors: Magro
authors: D
authors: D
authors: Ajzenberg
authors: M-L
authors: ML
authors: Dardé
authors: E
authors: E
authors: Dei-Cas
authors: I
authors: I
authors: Yakoub-Agha
mesh_terms: D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects; D005260:Female; D005838:Genotype; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D008174:Lung Diseases, Parasitic / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000469:parasitology; D012307:Risk Factors; D014122:Toxoplasma / Q000145:classification / Q000235:genetics / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D014184:Transplantation, Homologous
chemical_list: D000981:Antiprotozoal Agents